Loading...
NPI 1033111778 · Wexford, PA · Physical Medicine & Rehabilitation Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Mark Mitros is a physical medicine & rehabilitation physician provider located in Wexford, Pennsylvania. This profile covers 12 Medicare and 9 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Mark Mitros |
| Address | 7000 Stonewood Dr Ste 151 |
| City | Wexford |
| State | PA |
| ZIP | 15090 |
| Taxonomy | Physical Medicine & Rehabilitation Physician |
| NPI Enumerated | August 12, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $552.3K |
| Medicare | $112K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 370 | $80 | $30.2K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 120 | $200 | $24.2K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 250 | $70 | $18.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 170 | $60 | $10.5K |
| 95911 | In this procedure, the provider performs nine or ten nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 50 | $150 | $7.5K |
| 95910 | In this procedure, the provider performs seven or eight nerve conduction studies, a diagnostic test to evaluate the function, especially the electrical conduction ability of the motor and sensory… | 50 | $130 | $6.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 30 | $110 | $3.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $100 | $3.2K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20 | $140 | $3K |
| 95913 | In this procedure, the provider performs 13 or more nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 10 | $210 | $2.3K |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
12 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0480 | 40 | 40 | 270 | $110 | $94.5K |
| G0482 | 27 | 50 | 130 | $190 | $43.2K |
| 80307 | 66 | 100 | 300 | $60 | $42.6K |
| G0481 | 58 | 60 | 100 | $150 | $37.4K |
| 99214 | 3,122 | 23,230 | 100 | $80 | $14.5K |
| 99213 | 16,228 | 22,370 | 70 | $60 | $7.7K |
| 95886 | 31 | 320 | 90 | $60 | $7.4K |
| 95913 | 55 | 60 | 20 | $200 | $5.9K |
| 95911 | 33 | 170 | 30 | $140 | $5.4K |
| 99204 | 4,717 | 10,290 | 30 | $110 | $5K |
Showing 1–10 of 12
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 6,400 | $40 | $223.9K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 1,580 | $60 | $94.8K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 910 | $70 | $60.6K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 490 | $110 | $52.2K |
| 95910 | In this procedure, the provider performs seven or eight nerve conduction studies, a diagnostic test to evaluate the function, especially the electrical conduction ability of the motor and sensory… | 350 | $120 | $39.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 370 | $80 | $28.6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 420 | $60 | $26.6K |
| 95911 | In this procedure, the provider performs nine or ten nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 140 | $130 | $18.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $30 | $7.6K |
How this provider's Medicaid billing volume and revenue compare to other Pennsylvania providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Pennsylvania median
9 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 20 | 710 | $80 | $1.7M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 59 | 130 | 310 | $60 | $769.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 90 | 210 | 730 | $40 | $689.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 275 | 8,160 | 210 | $60 | $68.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 4,011 | 8,870 | 240 | $40 | $56.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 247 | 1,410 | 60 | $90 | $30.5K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 7 | 150 | 150 | $70 | $25.9K |
| 95911 | In this procedure, the provider performs nine or ten nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 17 | 50 | 50 | $130 | $19.9K |
| 95910 | In this procedure, the provider performs seven or eight nerve conduction studies, a diagnostic test to evaluate the function, especially the electrical conduction ability of the motor and sensory… | 3 | 30 | 70 | $100 | $11.3K |
Other providers in the same ZIP code as Mark Mitros, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Care Unlimited Inc. | PA | Home Health Agency | $0 | $32.4M |
| Foundation Radiology Group PC | PA | Diagnostic Radiology Physician | $0 | $8.8M |
| Miracle Dental Associates | PA | General Practice Dentistry | $0 | $5.7M |
| Nishant Gandhi | PA | Pain Medicine (Anesthesiology) Physician | $387.9K | $1M |
| Western PA Surgery Center, Wexford Branch, LLC | PA | Ambulatory Surgical Clinic/Center | $915.9K | $0 |
| Allegheny Clinic | PA | Radiology Clinic/Center | $842K | $0 |
| Mccandless-franklin Park Ambulance Authority | PA | Land Ambulance | $443.1K | $367.4K |
| Allegheny Clinic | PA | Ambulatory Surgical Clinic/Center | $434.8K | $0 |
| Joshua Hagen | PA | Dermatology Physician | $367.4K | $0 |
| Matthew Klocek | PA | Ophthalmology Physician | $331.1K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.